We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
AUM
$245M
AUM Growth
+$18.2M
Cap. Flow
+$2.74M
Cap. Flow %
1.12%
Top 10 Hldgs %
66.41%
Holding
667
New
60
Increased
182
Reduced
81
Closed
82

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$3.91M
2
SIBN icon
SI-BONE Inc
SIBN
+$2.35M
3
NEO icon
NeoGenomics
NEO
+$1.8M
4
MASS icon
908 Devices
MASS
+$1.68M
5
HCAT icon
Health Catalyst
HCAT
+$1.18M

Sector Composition

Rank Sector Weight
1 Healthcare 22.08%
2 Financials 4.47%
3 Technology 3.55%
4 Industrials 1.31%
5 Consumer Discretionary 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMFG icon
651
Sumitomo Mitsui Financial
SMFG
$164B
-160
Closed -$2.68K
SPYG icon
652
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51B
-1
Closed -$105
SSRM icon
653
SSR Mining
SSRM
$5.54B
-111
Closed -$2.71K
TD icon
654
Toronto Dominion Bank
TD
$198B
-19
Closed -$1.52K
TSCO icon
655
Tractor Supply
TSCO
$15.8B
-9
Closed -$489
TTC icon
656
Toro Company
TTC
$8.72B
-52
Closed -$3.96K
TW icon
657
Tradeweb Markets
TW
$20.8B
-20
Closed -$2.22K
UL icon
658
Unilever
UL
$141B
-20
Closed -$1.3K
USMV icon
659
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
-3
Closed -$245
VCYT icon
660
Veracyte
VCYT
$4.77B
-750
Closed -$25.7K
VRTX icon
661
Vertex Pharmaceuticals
VRTX
$122B
-10
Closed -$3.92K
VTR icon
662
Ventas
VTR
$44.7B
-20
Closed -$1.43K
NBIS
663
Nebius Group N.V.
NBIS
$47.8B
-2
Closed -$234
PHLT
664
DELISTED
Performant Healthcare Inc
PHLT
-756,000
Closed -$5.84M
FIG
665
Figma
FIG
$12.6B
-16
Closed -$856

Similar funds

HighMark Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, HighMark Wealth Management held 667 positions worth $245M, up 8% from $227M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q4 2025 filing shows 60 new, 182 increased, 81 reduced and 82 closed positions. Its largest new stake was 908 Devices: 241,000 shares worth $1.27M. The largest sale was Performant Healthcare Inc, an estimated $5.84M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q4 2025 buy was 908 Devices: 241,000 shares worth $1.27M.
  • HighMark Wealth Management added most to Axogen in Q4 2025, an estimated $3.91M increase.
  • HighMark Wealth Management's biggest Q4 2025 reduction was AnaptysBio, cutting an estimated $1.6M.
  • HighMark Wealth Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $5.84M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $245M portfolio in Q4 2025.
  • HighMark Wealth Management opened 60 new positions and closed 82 in Q4 2025.
  • HighMark Wealth Management's portfolio value rose 8% quarter-over-quarter to $245M.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.